FDA to Revise 20-Year-Old ICH Reproductive Risks Guideline
The FDA published an ICH-developed revision to its industry guideline on the detection of reproductive risks in new drugs. Source: Drug Industry Daily
The FDA published an ICH-developed revision to its industry guideline on the detection of reproductive risks in new drugs. Source: Drug Industry Daily
The FDA published guidance assisting sponsors in evaluating the effects of psychoactive drugs on the ability to operate a motor vehicle, saying reducing the incidence of accidents is a public…
The PTO’s Patent Trial and Appeal Board ruled against a Purdue Pharma patent on OxyContin, agreeing with Amneal Pharmaceuticals on the patent’s obviousness. Source: Drug Industry Daily
Under a new category of generic ANDAs eligible for priority review, the FDA will prioritize applications likely to be ready for approval shortly after the six months of marketing exclusivity…
Danish drug regulators have moved to shut down a drug importer and repackager due to its inadequate quality control systems, the Danish Medicines Agency said. Source: Drug Industry Daily
The public listing that is expected to value the business at around $46 billion. Source: BioSpace
Dr Barron was Executive VP, Head of Global Product Development, and CMO of Roche, responsible for all the products in the combined portfolio of Roche and Genentech. Source: BioSpace
The company will explore opportunity to close facilities during second half of 2019. Source: BioSpace
The company announced the pricing of its initial public offering of 6,667,000 common shares at an initial public offering price of $15.00 per common share. Source: BioSpace
The cash will allow the company to hire scientists to conduct preclinical research into a potential treatment for DMD. Source: BioSpace